Diagnosis and treatment strategy for advanced severe lung cancer

Zhan-hong Xie; Cheng-zhi Zhou; Yin-yin Qin; Ming Ouyang; Shi-yue LI; Rong-chang Chen; Nan-shan Zhong

Return

Diagnosis and treatment strategy for advanced severe lung cancer

Author: Zhan-hong XIE ¹ ; Cheng-zhi ZHOU ¹ ; Yin-yin QIN ¹ ; Ming OUYANG ¹ ; Shi-yue LI ¹ ; Rong-chang CHEN ¹ ; Nan-shan ZHONG ¹
Author Information

1. Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of Guangzhou Medical University Guangzhou 510120, China
Publication Type:Journal Article
Keywords: advanced lung cancer; severe condition; diagnosis and treatment strategy
From: Chinese Journal of Practical Internal Medicine 2019;39(05):416-419
CountryChina
Language:Chinese
Abstract: Advanced severe lung cancer means the stage IIIB, IIIC, and IV lung cancer patients with a PS score of 2 to 4 points due to various related causes of lung cancer itself or the complication of anti-tumor drugs, with a high probability of benefiting from the existing systemic anti-tumor treatments. The diagnosis and treatment strategies emphasize the implementation of minimally invasive dynamic monitoring mutation targets and curative effects. Every drug that is useful to the patient should be used as possible, and making the best use of every drug as possible with the help of respiratory support therapy. Specific treatment concepts include combination therapy,alternating medication, paying equal attention to systemic therapy and local therapy, PS score assessment, upgrading and downgrading of drug use, and simultaneous treatment of cancer and lung itself.